Pfizer withdraws all lots of OXBRYTA (voxelotor)
Pfizer has voluntarily withdrawn all lots of OXBRYTA (voxelotor), a treatment for sickle cell disease (SCD), from the market due
Read MoreFaulty Pharmaceutical Drugs Resources
Pfizer has voluntarily withdrawn all lots of OXBRYTA (voxelotor), a treatment for sickle cell disease (SCD), from the market due
Read MoreQuinapril is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the action of a substance in the body that
Read MoreFDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk to Public Health The U.S. Food
Read MoreThe heart drug valsartan is being recalled in 22 countries. It contains a chemical that poses a potential cancer risk.
Read MoreAttention Women. Zofran has been linked to serious birth defects. FDA Warns Against Zofran Use in Pregnancy The FDA has
Read MoreMcNeil Consumer Healthcare notified the public of a recall of seven lots (approximately 574,000 bottles) of Infants’ TYLENOL Oral Suspension,
Read More“As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave
Read MoreJohnson & Johnson issued another recall notice today for Tylenol. Â This recall is due to reports of a musty and
Read More